PowerUp Acquisition Corporation News - PWUP | ADVFN

S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
PowerUp Acquisition Corporation (PWUP)
PowerUp Acquisition Corporation (PWUP) News

PowerUp Acquisition Corporation (PWUP)

11.43

0.00

( 0.00% )

Updated: 09:39:13

Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

Highlights Transaction Valuation: The transaction values Aspire Biopharma, Inc. at a pre-money equity value of...

Aspire Biopharma, Inc. Signs Letter of Intent to Create a Publicly Listed, Drug Delivery Company Through a Business Combination with PowerUp Acquisition Corp.

Humacao, PR and New York, NY, July 31, 2024 (GLOBE NEWSWIRE) -- Aspire Biopharma, Inc. (“Aspire” or the...

PowerUp Acquisition Corp. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q

New York, NY, June 05, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 20, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP...

PowerUp Acquisition Corp. Announces Postponement of Extraordinary General Meeting of Shareholders

New York, NY, May 16, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (the “Company”) (Nasdaq: PWUP...

PowerUp Acquisition Corp. and Visiox Pharmaceuticals, Inc. Announce Filing of Registration Statement on Form S-4 to the SEC in Connection with the Previously Announced Proposed Business Combination

Tarrytown, NY and New York, NY, Jan. 29, 2024 (GLOBE NEWSWIRE) -- PowerUp Acquisition Corp. (“PowerUp”...

Visiox Pharmaceuticals, Inc., a Commercial-Stage Biopharmaceutical Company to be Listed on Nasdaq Through a Business Combination with PowerUp Acquisition Corp.

Tarrytown, NY and New York, NY, Dec. 27, 2023 (GLOBE NEWSWIRE) -- Visiox Pharmaceuticals, Inc. (“Visiox” or...

Amended Current Report Filing (8-k/a)

0001847345 true This Amendment to Form 8-K (this "Form 8-K/A") to our Current Report on Form 8-K filed with the Securities and...

Additional Proxy Soliciting Materials (definitive) (defa14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

0001847345 false 00-0000000 0001847345 2023-04-27 2023-04-27 0001847345...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE...

Annual Report (10-k)

00-000000000018473452022FYfalse000071875007187500P10D0000P20D0.524496575718750062500000.110.110.0000P20DP5Y0001847345pwup:PublicWarrantsMember2022...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCH...

Statement of Ownership (sc 13g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G ...

Amended Statement of Ownership (sc 13g/a)

UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 SCHEDULE 13G/A Under the Securities Exchange Act of 1934...

1
Next

barnyarddog

barnyarddog 4 weeks ago

barnyarddog

barnyarddog 4 weeks ago

Aspire Pharma acquires Canute to expand strategic portfolio

7 October 2024
https://pharmaceuticalmanufacturer.media/pharma-manufacturing-news/latest-pharmaceutical-manufacturing-news/aspire-pharma-acquires-canute-to-expand%C2%A0strategic-portfolio/

barnyarddog

barnyarddog 4 weeks ago

About the Company

https://aspirebiolabs.com/about/

I dont know if this is the merging company...

barnyarddog

barnyarddog 4 weeks ago

Aspire Biopharma, Inc., and PowerUp Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-listed Biopharmaceutical Company Driving Breakthrough Innovations in FDA Approved Drugs, Nutraceuticals and Supplements

September 03, 2024
https://www.globenewswire.com/news-release/2024/09/03/2939657/0/en/Aspire-Biopharma-Inc-and-PowerUp-Acquisition-Corp-Announce-Business-Combination-Agreement-to-Create-Nasdaq-listed-Biopharmaceutical-Company-Driving-Breakthrough-Innovations-in-FDA-.html

Aspire Overview

Aspire Biopharma, Inc. is a privately held, early-stage biopharmaceutical technology company founded in 2021. The Company is engaged in the business of developing and marketing a disruptive technology for novel delivery mechanisms for “do no harm” FDA approved drugs, nutraceuticals and supplements. Aspire has developed and acquired technologies that are a Novel Soluble Formulation which address emergencies and drug efficacy, dosage management, patient compliance and safety and rapid response and absorption time when required and desired.

PowerUp Acquisition

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions